Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)

K. G. Parhofer, K. I. Birkeland, R. DeFronzo, S. Del Prato, A. Bhaumik, A. Ptaszynska

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)'. Together they form a unique fingerprint.

Medicine & Life Sciences